Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Not Yet Recruiting NCT07766369

A Study to Assess Potential Drug-Drug Interactions of E2086 in Healthy Participants

Conditions: Healthy Volunteers

Sex: All

Ages: 18 Years – 55 Years

Healthy volunteers: Yes

Phase: PHASE1

Enrollment: 93

Sponsor: Eisai Inc.

Location: PPD Austin Clinical Research Unit (CRU)- Phase 1 Austin Texas

Summary

The primary purpose of this study is to assess potential drug-drug interactions of E2086 when coadministered orally with Itraconazole, Carbamazepine, Midazolam, Dextromethorphan, Bupropion, or Combined Oral Contraceptives in Healthy Participants

Eligibility Criteria

Inclusion Criteria: 1. Body Mass Index (BMI) greater than or equal to (≥) 18 and less than (\

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07766369). StuddyBuddy aggregates publicly available trial information.